These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20106598)

  • 41. What is your diagnosis? Peritoneal effusion from a dog.
    Dell'Orco M; Bertazzolo W; Paccioretti F
    Vet Clin Pathol; 2009 Sep; 38(3):367-9. PubMed ID: 19351338
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PCR follow-up examination after treatment of canine leishmaniosis (CaL).
    Steuber S; Moritz A; Schirrmann I; Greiner M
    Tokai J Exp Clin Med; 1998 Dec; 23(6):285-92. PubMed ID: 10622624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renal dialysis and long-term treatment of a dog with kidney disease associated with canine leishmaniosis.
    Baneth G; Segev G; Mazaki-Tovi M; Chen H; Kuzi S
    Parasit Vectors; 2018 Mar; 11(1):151. PubMed ID: 29554974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glomerulonephritis in dogs with canine leishmaniasis.
    Benderitter T; Casanova P; Nashkidachvili L; Quilici M
    Ann Trop Med Parasitol; 1988 Aug; 82(4):335-41. PubMed ID: 3252757
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determination of CD4+ and CD8+ T cells in the peripheral blood of dogs with leishmaniosis before and after prolonged allopurinol monotherapy.
    Papadogiannakis E; Andritsos G; Kontos V; Spanakos G; Koutis C; Velonakis E
    Vet J; 2010 Nov; 186(2):262-3. PubMed ID: 19733103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Guidelines for treatment of leishmaniasis in dogs.
    Oliva G; Roura X; Crotti A; Maroli M; Castagnaro M; Gradoni L; Lubas G; Paltrinieri S; Zatelli A; Zini E
    J Am Vet Med Assoc; 2010 Jun; 236(11):1192-8. PubMed ID: 20513197
    [No Abstract]   [Full Text] [Related]  

  • 47. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
    Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
    Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Canine leishmaniasis associated with pericardial effusion in a 4-year-old dog.
    Sebastián-Marcos P; Santarelli G; Gómez S; Palacio MJF
    J Vet Cardiol; 2019 Jun; 23():32-37. PubMed ID: 31174727
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Electrocardiographic alterations during treatment of mucocutaneous leishmaniasis with meglumine antimoniate and allopurinol.
    Antezana G; Zeballos R; Mendoza C; Lyevre P; Valda L; Cardenas F; Noriega I; Ugarte H; Dedet JP
    Trans R Soc Trop Med Hyg; 1992; 86(1):31-3. PubMed ID: 1566297
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Paraparesis caused by vertebral canal leishmaniotic granuloma in a dog.
    Cauduro A; Favole P; Lorenzo V; Simonetto L; Barda B; Cantile C; Asperio RM
    J Vet Intern Med; 2011; 25(2):398-9. PubMed ID: 21281352
    [No Abstract]   [Full Text] [Related]  

  • 51. The effect of intravenous or subcutaneous administration of meglumine antimonate (Glucantime) in dogs with leishmaniasis. A randomized clinical trial.
    Slappendel RJ; Teske E
    Vet Q; 1997 Mar; 19(1):10-3. PubMed ID: 9225422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Meeting "Visceral leishmaniasis in Maghreb", 2-4 April 2015 in Tunis. Recommendations].
    Aoun K; Laamrani El Idrissi A; Harrat Z; Marty P
    Bull Soc Pathol Exot; 2015 Aug; 108(3):229-30. PubMed ID: 26002086
    [No Abstract]   [Full Text] [Related]  

  • 53. Evaluation of renal and hepatic functions in dogs naturally infected by visceral leishmaniasis submitted to treatment with meglumine antimoniate.
    Ikeda-Garcia FA; Lopes RS; Ciarlini PC; Marques FJ; Lima VM; Perri SH; Feitosa MM
    Res Vet Sci; 2007 Aug; 83(1):105-8. PubMed ID: 17150234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Update on the diagnosis and management of Leishmania spp infections in dogs in the United States.
    Freeman K
    Top Companion Anim Med; 2010 Aug; 25(3):149-54. PubMed ID: 20937498
    [No Abstract]   [Full Text] [Related]  

  • 55. A simple duplex-PCR protocol for routine diagnosis and follow up of canine leishmaniasis.
    Franceschi A; Compagnoni F; Mancianti F
    Parassitologia; 2007 Jun; 49(1-2):43-8. PubMed ID: 18412042
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in the concentration of anti-Leishmania antibodies in saliva of dogs with clinical leishmaniosis after short-term treatment.
    Cantos-Barreda A; Escribano D; Cerón JJ; Tecles F; Bernal LJ; Martínez-Subiela S
    Vet Parasitol; 2018 Apr; 254():135-141. PubMed ID: 29656998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum apolipoprotein-A1 as a possible biomarker for monitoring treatment of canine leishmaniosis.
    Escribano D; Tvarijonaviciute A; Kocaturk M; Cerón JJ; Pardo-Marín L; Torrecillas A; Yilmaz Z; Martínez-Subiela S
    Comp Immunol Microbiol Infect Dis; 2016 Dec; 49():82-87. PubMed ID: 27865270
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Visceral leishmaniasis and disseminated intravascular coagulation in a dog.
    Font A; Gines C; Closa JM; Mascort J
    J Am Vet Med Assoc; 1994 Apr; 204(7):1043-4. PubMed ID: 8045804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Seizures as a Consequence of Hyperviscosity Syndrome in Two Dogs Naturally Infected with Leishmania infantum.
    Proverbio D; Spada E; Perego R; de Giorgi GB
    J Am Anim Hosp Assoc; 2016; 52(2):119-23. PubMed ID: 26808431
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Parasitological and immunological progress control during and after chemotherapy of canine leishmaniasis].
    Deplazes P; Arnold P; Skaggs J; Gessler M
    Schweiz Arch Tierheilkd; 1992; 134(2):85-93. PubMed ID: 1566026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.